Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
BLOG
EVENT CALENDAR
COLUMNS
WHITE PAPERS
THE MAGAZINE
  Pharmaceutical Technology Europe E-Alert
 
27 November 2012

IN THIS ISSUE
• Industry clinical trials
• FDA Guidance
• Pharma golden era
• US compounding crisis
Janssen, Merck, and Eli Lilly Form Industry Collaboration
Janssen Research & Development has announced the formation of a global cross-pharmaceutical Investigator Databank to improve efficiencies of industry-sponsored clinical trials. More...
 
FDA Adopts Final Version of Q11 Guidance
FDA has announced the availability of the guidance Q11 Development and Manufacture of Drug Substances, which describes approaches to developing and understanding the manufacturing process of a drug substance. More...
 
A Golden Era for Pharma in 2020
More favourable conditions for the pharmaceutical industry, including a “golden era  of renewed productivity and prosperity”, have been forecast in a new report from  analyst firm PricewaterhouseCoopers. More...
 
Legislators Request Info on Link Between Drug Shortages and Increased Reliance on Compounding
In the wake of US congressional hearings into the events leading up to an outbreak of fungal meningitis caused by contaminated compounded medicines, House Democrats have requested an inquiry to be conducted into factors leading to an increased reliance on compounded products. More...
 
Thermo Fisher Scientific Opens New Manufacturing Facility in China
Thermo Fisher Scientific has officially opened  its new manufacturing facility in Suzhou, China, which will manufacture life-sciences consumables and equipment, and establish local production capabilities. More...
 
Get the Latest Updates on Twitter
We regularly tweet the latest news and rumours hitting the web about the pharmaceutical industry. Follow us to keep up to date. More...
Key Topics:

Latest blog posts
A Tough Time for FDA at House Hearings
When Disaster Strikes at Home
Color-Changing Sealant Technology Enhances Package Security
More blog posts

Latest articles
Optimizing Early-Stage Drug Development
Examining the Growing Challenge of Extractables and Leachables
EU Sets Guidelines for Biosimilar Monoclonal Antibodies
More articles

Upcoming events
FT Global Pharmaceutical & Biotechnology Conference (4–5 December | UK)
IVT's 3rd Annual Stability Programs Forum (4–6 December | US)
5th Annual Contract Manufacturing (7–8 December | UK)
More events

Products/Service Profiles
TSI Instruments

Real-Time Viable Particle Counters, like TSI’s BioTrak™ Products, are a new Rapid Microbial Methods (RMM) technique, which has recently been released to the market. Read More
Survey
2012 has been touted as a crucial year of the so-called patent cliff. Do you think the impact of patent expiries has been better or worse than expected?
 
Better 46%
 
 
Worse 14%
     
 
As predicted 40%

This week we would like to know...

Compared with 2011, has your company attended more or less industry trade shows in 2012?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.